Page last updated: 2024-09-03

reveromycin a and Bone Loss, Osteoclastic

reveromycin a has been researched along with Bone Loss, Osteoclastic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Asano, Y; Goto, S; Kako, S; Kawatani, M; Maeda, H; Miyazawa, K; Osada, H; Tabuchi, M1
Kawatani, M; Osada, H1
Goto, S; Kadota, M; Kawatani, M; Maeda, H; Miyazawa, K; Osada, H; Tabuchi, M; Tanaka, M; Yabumoto, T; Yamane, C; Yoshizako, M1
Kanoh, N; Kato, M; Kawatani, M; Lee, KH; Nagai, K; Nakagawa, H; Osada, H; Shinki, T; Stern, PH; Takami, M; Woo, JT; Yonezawa, T1
Cha, BY; Nagai, K; Teruya, T; Woo, JT; Yonezawa, T1

Reviews

2 review(s) available for reveromycin a and Bone Loss, Osteoclastic

ArticleYear
Osteoclast-targeting small molecules for the treatment of neoplastic bone metastases.
    Cancer science, 2009, Volume: 100, Issue:11

    Topics: Animals; Antineoplastic Agents; Biphenyl Compounds; Bone Neoplasms; Bone Resorption; Cell Differentiation; CSK Tyrosine-Protein Kinase; Diphosphonates; Ethers; Humans; Integrin alphaVbeta3; Osteoclasts; Protein-Tyrosine Kinases; Pyrans; Spiro Compounds; src-Family Kinases

2009
Pharmacological topics of bone metabolism: antiresorptive microbial compounds that inhibit osteoclast differentiation, function, and survival.
    Journal of pharmacological sciences, 2008, Volume: 106, Issue:4

    Topics: Animals; Apoptosis; Bacteria; Bone Density Conservation Agents; Bone Resorption; Cell Differentiation; Cell Survival; Cyclosporine; Depsipeptides; Fungi; Heterocyclic Compounds, 3-Ring; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Osteoclasts; Prodigiosin; Pyrans; Spiro Compounds; Tacrolimus

2008

Other Studies

3 other study(ies) available for reveromycin a and Bone Loss, Osteoclastic

ArticleYear
Local administration of ReveromycinA ointment suppressed alveolar bone loss in mice.
    Journal of pharmacological sciences, 2021, Volume: 147, Issue:1

    Topics: Administration, Topical; Alveolar Bone Loss; Animals; Bone Resorption; Disease Models, Animal; Male; Mice, Inbred C57BL; Mice, Knockout; Ointments; Osteoclasts; Periodontal Diseases; Periodontitis; Pyrans; Spiro Compounds

2021
Effect of Reveromycin A on experimental tooth movement in OPG-/- mice.
    Journal of dental research, 2012, Volume: 91, Issue:8

    Topics: Acid Phosphatase; Alkaline Phosphatase; Alveolar Process; Animals; Biomarkers; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Cell Count; Dental Alloys; Disease Models, Animal; Injections, Intraperitoneal; Isoenzymes; Male; Maxilla; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Mutation; Nickel; Orthodontic Wires; Osteitis Deformans; Osteoclasts; Osteoporosis; Osteoprotegerin; Pyrans; Spiro Compounds; Tartrate-Resistant Acid Phosphatase; Titanium; Tooth Movement Techniques; X-Ray Microtomography

2012
Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, Mar-21, Volume: 103, Issue:12

    Topics: Acids; Animals; Apoptosis; Bone and Bones; Bone Resorption; Culture Media; Female; Isoleucine-tRNA Ligase; Mice; Mice, Inbred Strains; Osteoclasts; Osteoporosis; Protein Biosynthesis; Pyrans; Rats; Rats, Sprague-Dawley; Spiro Compounds

2006